Topics

Steven J. Fliesler, PhD, SUNY Distinguished Professor and the Meyer H. Riwchun Endowed Chair Professor of ophthalmology, has been awarded a $2.2 million grant from the National Eye Institute of the National Institutes of Health to better understand a rare cause of blindness that strikes young children.

New stem cell research led by Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, has identified novel therapeutic targets for the treatment of multiple sclerosis (MS) and other inflammatory diseases.

Nonprescription use of Ritalin may cause irreversible structural changes in certain areas of the brain, according to researchers in the Department of Pharmacology and Toxicology and UB’s Clinical and Research Institute on Addictions (CRIA).

Kenneth E. Leonard, PhD, professor of psychiatry and director of the UB Clinical and Research Institute on Addictions (CRIA), and Peter L. Elkin, MD, professor and chair of biomedical informatics, have been awarded a two-year, $386,013 grant from the National Institute on Alcohol Abuse and Alcoholism to assess what risks may occur for people with alcohol use disorder (AUD) who use prescription painkillers.

Jennifer A. Martin, a doctoral student in the Department of Pharmacology and Toxicology, has received a prestigious Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience Award from the National Institutes of Health (NIH).

The Jacobs School of Medicine and Biomedical Sciences is using a New York State Department of Health grant to support the expansion of primary care residency and medical student training in ambulatory settings throughout Western New York.

Research by Richard M. Gronostajski, PhD, professor of biochemistry, reveals that the absence of one copy of a single gene in the brain causes a rare, as-yet-unnamed neurological disorder.

The National Institutes of Health is funding researchers in the Department of Pharmacology and Toxicology to study the effects of drinking, smoking and marijuana use during pregnancy.

An innovative, cost-effective program at more than a dozen hospitals in Western New York provides medication-assisted treatment to opioid use disorder patients in emergency departments (EDs) and rapidly transitions them into long-term treatment at a community clinic, all within about 48 hours.

Pinaki Sarder, PhD, assistant professor of pathology and anatomical sciences, is using funding from the National Institutes of Health to refine development of computational tools to quantify renal structures in human diabetic nephropathy (DN) biopsies.

Cytocybernetics, a UB spinoff founded by two Jacobs School of Medicine and Biomedical Sciences faculty members, has received a $250,000 Small Business Innovation Research award from the National Institute of Mental Health (NIMH) to move into a new market: neuronal drug development.

Interprofessional collaboration is a key component in addressing the nation’s opioid epidemic, students from the Jacobs School of Medicine and Biomedical Sciences and other UB schools were told during the third annual forum on the topic.

The recipients of this year’s Dean’s and Nader Research Fellowships have a wide range of research interests and knowledge.

Andrew H. Talal, MD, professor of medicine in the Division of Gastroenterology, Hepatology and Nutrition, has been appointed to New York Gov. Andrew M. Cuomo’s task force that will advise the state on its Hepatitis C Virus (HCV) Elimination Campaign.

Research led by Jonathan F. Lovell, PhD, associate professor of biomedical engineering, has provided a breakthrough in efforts to boost the efficacy of malarial transmission-blocking vaccines (TBV).

The so-called mystery paralysis that has now affected more than 70 children in the United States this year is understandably causing concern among parents, but it is extremely rare, according to Mark D. Hicar, MD, PhD, assistant professor of pediatrics in the Division of Infectious Diseases.

Gross anatomy class — arguably the most memorable class that medical students take — has a new home.

Research by Yun Wu, PhD, assistant professor of biomedical engineering, has led to a cancer-spotting tool that health care providers could eventually use in areas that lack hospitals, clinics and other treatment centers.

Paresh Dandona, MD, PhD — who did the first pilot studies on how drugs developed for Type 2 diabetes patients might benefit adults with Type 1 diabetes — is launching a major, interventional study with 114 patients in Buffalo and Glasgow, Scotland.

A study published in JAMA Pediatrics that rigorously assessed how the home environments of young children who are genetically at high risk for obesity can influence whether they become overweight or obese is being praised by University at Buffalo child obesity experts.